Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R35CA253059, RO1CA258390, R01CA254970)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
- License Information
-
More Information
Article History
Received: 3 March 2022
Revised: 14 April 2022
Accepted: 20 April 2022
First Online: 29 April 2022
Competing interests
: OT is currently an employee of AstraZeneca and has stock ownership in AstraZeneca. All other authors declare that they have no conflict of interest.
